SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a - 16 OR 15d - 16 OF
THE SECURITIES EXCHANGE ACT OF 1934
For the month of May, 2007
SkyePharma PLC
SkyePharma PLC, 105 Piccadilly, London W1J 7NJ England
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40F.
Form 20-F X Form 40-F
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes No X
If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- _______
For Immediate Release 15 MAY 2007
SkyePharma PLC - Annual Information Update
In accordance with the requirements of Prospectus Rule 5.2, the following
summarises the information and documents published, or made available to the
public, by the Company between 3 May 2006 and 14 May 2007 inclusive. The
information referred to in this update was up to date at the time it was
published but some information may now be out of date.
1. Announcements via RNS
The following UK regulatory announcements have been made via RNS a Regulatory
Information Service and can be obtained from the London Stock Exchange website
at www.londonstockexchange.com or the Company's website at www.skyepharma.com
Date Announcement
3 May 2006 Share Purchase Plan
8 May 2006 Flutiform Deal
8 May 2006 Conference Call Details
17 May 2006 Board Appointment
19 May 2006 Director Declaration
22 May 2006 First Horizon Deal
31 May 2006 Asco Presentation
31 May 2006 Share Purchase Plan
12 Jun 2006 Re Convertible Bonds
15 Jun 2006 Notification of Shares
21 Jun 2006 Business Review
28 Jun 2006 AGM Statement
30 Jun 2006 Re: DepoBupivacaine Rights
4 Jul 2006 Share Purchase Plan
10 Jul 2006 Notification of Shares
28 Jul 2006 NASDAQ for Compliance
1 Aug 2006 FDA Filing
1 Aug 2006 Share Purchase Plan
4 Aug 2006 Notification of Shares
8 Aug 2006 Adviser Update
11 Aug 2006 Re: Share Price Movement
21 Aug 2006 Appointment of Auditor
31 Aug 2006 Share Purchase Plan
5 Sep 2006 Notice of Results
6 Sep 2006 European Flutiform Deal
22 Sep 2006 Personnel Changes
28 Sep 2006 Interim Results
4 Oct 2006 Positive Data & EU Filing
4 Oct 2006 Director Shareholding
9 Oct 2006 Company Secretary Appointment
20 Oct 2006 Notification of Interest
24 Oct 2006 NDA for Zileuton CR
25 Oct 2006 Notification of Shares
27 Oct 2006 Notification of Shares
31 Oct 2006 Conference Presentation
2 Nov 2006 Share Purchase Plan
7 Nov 2006 Positive Flutiform Update
14 Nov 2006 Board Appointment
20 Nov 2006 Presentation at Conference
22 Nov 2006 Notification of Interests
24 Nov 2006 Notification of Interests
27 Nov 2006 Notification of Shares
28 Nov 2006 Solaraze Approval
30 Nov 2006 Share Purchase Plan
18 Dec 2006 FDA Approves Certihaler
18 Dec 2006 Transparency Directive
19 Dec 2006 Major Interest in Shares
27 Dec 2006 GBP35million Fundraising
28 Dec 2006 Notification of Shares
3 Jan 2007 Share Purchase Plan
4 Jan 2007 Notification of Shares
9 Jan 2007 Injectable Sale & Placing
9 Jan 2007 UK Release Important Details
16 Jan 2007 Circular Posting
22 Jan 2007 Notification of Shares
29 Jan 2007 Notification of Interests
1 Feb 2007 Share Purchase Plan
8 Feb 2007 EGM Statement
14 Feb 2007 Presentation at Conference
20 Feb 2007 Notification of Shares
1 Mar 2007 Share Purchase Plan
9 Mar 2007 Presentation at Conference
12 Mar 2007 Holding(s) in Company
13 Mar 2007 Holding(s) in Company
15 Mar 2007 Agreement for Zileuton CR
26 Mar 2007 Completion of Disposal
26 Mar 2007 Total Voting Rights
2 Apr 2007 Interest in Shares
2 Apr 2007 Interest in Shares
3 Apr 2007 Annual Information Update
3 Apr 2007 Interest in Shares
3 Apr 2007 Director Shareholding
13 Apr 2007 Regulatory Application
17 Apr 2007 Holding(s) in Company
18 Apr 2007 EGM Circular
18 Apr 2007 Circ re. Incentive Plan
23 Apr 2007 Regulatory Approval
26 Apr 2007 Final Results
1 May 2007 Re: UBS Conference
1 May 2007 Further re Final Results
3 May 2007 Director/PDMR Shareholding
4 May 2007 Delist from NASDAQ
4 May 2007 EGM Result
4 May 2007 Director Shareholding
14 May 2007 Research Update
2. Documents filed at Companies House
All of the documents listed below were filed with the Registrar of Companies in
England and Wales on or around the dates indicated. Copies of the documents
filed with the Registrar of Companies can be obtained from Companies House
(www.companieshouse.gov.uk)
Date of Filing Brief Description of document(s) filed
07/06/2006 288a Director appointed
27/06/2006 288a Director appointed
11/07/2006 288b Director resigned
11/07/2006 288b Director resigned
11/07/2006 288b Director resigned
11/07/2006 Res09 Resolutions
07/08/2006 AA Annual Accounts
16/08/2006 AUD Auditor's resignation
06/10/2006 288a Secretary appointed
11/10/2006 288b Secretary resigned
29/11/2006 288a Director appointed
29/11/2006 288b Director resigned
09/01/2007 395 Particulars of Mortgage/Charge
09/01/2007 395 Particulars of Mortgage/Charge
11/01/2007 395 Particulars of Mortgage/Charge
12/02/2007 363 Return made up to 31/12/06
15/02/2007 395 Particulars of Mortgage/Charge
20/03/2007 RES10 Resolutions
3. Documents published or sent to Shareholders or filed with the UK Listing
Authority viewing facility at:
Financial Services Authority
The North Colonnade
Canary Wharf
London
E14 5HS
Date Document
1 Jun 2006 Annual Report and Notice of Meeting
12 Oct 2006 Interim Report
15 Jan 2007 EGM Circular and Notice of Meeting
18 Apr 2007 EGM Circular and Notice of Meeting
Copies of the above documents can be obtained from the Company Secretary at:
105 Piccadilly
London
W1J 7NJ
Name of contact and telephone number for queries:
John Murphy
Company Secretary
SkyePharma PLC
Tel: 020 7491 1777
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
SkyePharma PLC
By: /s/ John Murphy
Name: John Murphy
Title:
Company Secretary
Date: May 15, 2007